MedPath

YEREVAN STATE MEDICAL UNIVERSITY

YEREVAN STATE MEDICAL UNIVERSITY logo
🇮🇳India
Ownership
Private
Established
1920-01-01
Employees
-
Market Cap
-
Website
http://www.ysmu.am

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

Effect of Atorvastatin on Carotid Intima Media Thickness

Phase 4
Conditions
Hypercholesterolemia
Essential Hypertension
Interventions
Drug: Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment
First Posted Date
2020-03-13
Last Posted Date
2020-03-13
Lead Sponsor
Yerevan State Medical University
Target Recruit Count
200
Registration Number
NCT04306627

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.